REGN5459
Regeneron
['regn5459', 'affinit']
"further development of this agent, as well as a strategy to modify the cd3 binding affinity as a way to mitigate crs in bispecific antibody therapy in myeloma are promising areas," of / said of regn5459 during #aacr23. 
Translating Hematologic Oncology Discoveries into Practice.